SpineJournal.gr

BOCA RATON, Fla.–(HSMN NewsFeed)–US Spine(R) is pleased to announce the commercial launch of the Preference 2 Complex Spine System(TM). The product has been in use at select sites throughout the spring and summer, with strong clinical feedback and results. The introduction of this product has improved the company’s pedicle screw business nearly 75% compared to last year at the same time.
The new system, which ushers the company into the complex spine market (estimated at more than $700 million), is a hook, rod and pedicle screw system with several implant options allowing multiple correction techniques and comprehensive instrumentation designed specifically to treat complex spinal pathologies. The system provides spine surgeons with a specialized solution to correct complex spinal pathologies such as scoliosis, kyphosis, trauma and tumors.

Advanced correction instrumentation, Cobalt Chrome Rods, Lateral Offset Connectors, Hooks, Rod-to-Rod Connectors and a Low-profile Cross Connector are among the many components that make up the system. All anchoring implants within the system feature the Helical Flange(R) Closure mechanism, which eliminates head splay and drastically reduces cross threading.

Leading spine surgeons with backgrounds in both pediatric and adult deformity developed the system with the goal of providing a low-profile, flexible and powerful offering that gives surgeons a no-compromise solution to treat complex spinal disorders.

“While we are primarily known as a developer of our Facet Fixation technology, we are very proud of our Preference 2 Complex Spine System and the impact it allows us to make within the Deformity, Tumor and Trauma market,” said US Spine’s Executive Vice President Paul Sendro. “The Preference 2 instrumentation has been designed from the ground-up with a full emphasis on complex spinal pathology. With specialized instrumentation, surgeons using the system are able to achieve greater precision and control.”

Source:   US Spine

BOCA RATON, Fla.–(HSMN NewsFeed)–US Spine(R), the leader in facet technologies for spine surgery, today announced that it has named Paul J. Sendro Executive Vice President. Sendro, who brings to US Spine nearly twenty years of medical device industry experience, will oversee the company’s Sales, Marketing, Professional Education and Business Development efforts.
Sendro, who most recently served as President and CEO of Vertebron, Inc., helped increase that global medical device company’s sales threefold in less than a year. Prior to his work for Vertebron, he served at Blackstone Medical, Inc. for six years, most recently as Vice President, Domestic Sales. While at Blackstone, he developed and implemented the company’s strategic sales plan for accelerated growth and profitability, lifting domestic sales from a run rate of 700k per month to over 9 million per month, through to acquisition.

Earlier in his career, Sendro was Director of Marketing, Trauma/Global for Stryker, Director of Product Development and Marketing for Stryker Japan and Marketing Manager at Synthes.

“We’re extremely proud to be adding Paul to our team,” said US Spine President and CEO, Doris Blake. “His successful track record in the medical device industry speaks for itself. We are confident that his strategic focus and uncanny ability to clearly assess situations and markets, develop and implement growth plans will be a key factor in our move to the next level of excellence and market prominence.”

Sendro received his Bachelor of Science degree at Carnegie Mellon University in Pittsburgh and his Masters of Business Administration from Adelphi University in Garden City, New York.